Billionaire entrepreneur and top adviser to President-elect Donald Trump, Elon Musk, touted that he has reaped the benefits of Ozempic after fellow top Trump adviser, Robert F. Kennedy Jr., suggested the trendy new class of drugs are bad for Americans' health.

Two of President-elect Trump’s top health nominees are on a collision course as the incoming administration faces a crucial decision on coverage for groundbreaking anti-obesity drugs. Mehmet Oz, Trump’s pick to run the Centers for Medicare and Medicaid Services,

“While no drug is without side effects, health problems associated with obesity almost certainly exceed the risks of GLP-1 agonists,” Musk said as early as Oct. 2023. GLP-1 agonists are a class of medications that can help manage Type 2 diabetes and obesity.

Elon Musk, the richest man in the world and self-described ‘First Buddy’, on Wednesday signalled his support for weight loss drugs in posts that are being seen as a shot at Robert F Kennedy Jr, whom US President-elect Donald Trump has picked to oversee the Department of Health and Human Services.

Biden officials recently proposed allowing Medicare to start covering GLP-1 medications to treat obesity. It's unclear whether Trump's administration will see it through.

Elon Musk recently shared a playful post on X, revealing he uses Mounjaro, a weight loss drug, to achieve his thinner look.

Elon Musk recently shared a post on X, revealing he uses the weight loss drug Mounjaro. Musk posed in a Santa Claus outfit by a holiday tree and captioned the post, "Ozempic Santa," later clarifying he uses Mounjaro.

Elon Musk has taken to X to reveal he's started taking a weight loss drug - and he even dressed up in a Santa Claus outfit to celebrate the occasion

Elon Musk has revealed he has switched to a more powerful weight-loss drug, sharing the news alongside a photo of himself dressed as Father Christmas. The SpaceX billionaire, 53, posted a picture of himself slimmed down in a red-and-white fur-lined suit with the caption: "Ozempic Santa".